Escalation and optimisation of primary breast cancer treatment with antibody-drug conjugates [0.03%]
抗体偶联药物在乳腺癌一线治疗中的升级与优化
Masakazu Toi
Masakazu Toi
Antibody-drug conjugates (ADCs) have become the standard of care for metastatic advanced breast cancers, regardless of tumour subtype. Optimal positioning and treatment sequences are being studied, and many new therapies and combinations ar...
Omitting sentinel lymph node biopsy in early breast cancer: too bold or the future? [0.03%]
早期乳腺癌省略哨兵淋巴结活检：大胆还是未来趋势？
Jianli Zhao,Ziyue Zhou,Wei Zhang et al.
Jianli Zhao et al.
Precise targeting cytotoxicity of antibody-drug conjugate combined with immunotherapy as first-line regimen for metastatic triple-negative breast cancer in ASCENT-04 [0.03%]
抗体药物偶联物联合免疫治疗作为转移性三阴性乳腺癌一线疗法的精准靶向细胞毒作用：ASCENT-04研究
Li Bian,Shaohua Zhang,Man Li et al.
Li Bian et al.
Omission of breast surgery in exceptional responders after neoadjuvant chemotherapy-what are future possibilities?-a narrative review [0.03%]
新辅助化疗后特殊反应者的乳房手术遗漏-未来有哪些可能性？-叙述性综述
Frances Phang,Anna Weiss
Frances Phang
Background and objective: Triple negative and human epidermal growth factor receptor 2 (HER2)-positive (+) tumors exhibit excellent response to systemic therapy and are known as "exceptional responders". Pathological comp...
Radiotherapy in breast cancer patients achieving nodal pathologic complete response after neoadjuvant therapy: a scoping review [0.03%]
新辅助治疗后淋巴结病理完全缓解的乳腺癌患者的放射治疗：系统综述
Francisco Pimentel Cavalcante,Amanda Cardoso,Marcelo Antonini et al.
Francisco Pimentel Cavalcante et al.
Background: Neoadjuvant chemotherapy (NAC) is widely accepted as standard treatment in breast cancer, particularly in cases of tumors with aggressive biology. NAC has increased the rates of breast-conserving surgery (BCS)...
De-escalation of axillary interventions in the management of breast cancer patients following neoadjuvant systemic treatment [0.03%]
新辅助系统治疗后的乳腺癌患者管理中的腋窝处理降级
Ashutosh Tondare,Mangesh A Thorat
Ashutosh Tondare
The role of axillary surgery in the management of breast cancer continues to evolve as our understanding of breast cancer biology improves, coupled with an increasing availability and efficacy of systemic therapy options. In the current con...
Contrast-enhanced mammography in high-dense breasts: a narrative review [0.03%]
高密度乳腺的造影乳房X线摄影：综述性文章
Daniele Ugo Tari,Marika Santarsiere,Davide Raffaele De Lucia et al.
Daniele Ugo Tari et al.
Background and objective: Contrast-enhanced mammography (CEM) combines iodine-based contrast agents with dual-energy imaging to enhance the detection of breast cancer, especially in women with dense breast tissue. Dense b...
Breast cancer screening for transgender individuals with breast cancer susceptibility genes [0.03%]
乳腺癌筛查针对具有乳腺癌易感基因的跨性别个体
Kamelah Abushalha,Andrew Ng,Soumya Pulipati et al.
Kamelah Abushalha et al.
Transgender individuals represent a growing and very heterogeneous population, yet there are no precise estimates of their breast cancer risk and equitable breast cancer screening guidelines. They have lower rates of healthcare utilization ...
Non-commonly prescribed physical exercises, disciplines and sports in breast cancer survivors: a narrative review [0.03%]
乳腺癌幸存者不常被推荐的物理锻炼、学科和运动：综述文章
Andrea Di Blasio,Teresa Morano,Alessandra Di Marco et al.
Andrea Di Blasio et al.
Background and objective: Physical activity is widely acknowledged as a cornerstone in enhancing the quality of life and recovery outcomes in breast cancer survivors (BCSs). Despite robust guidelines emphasizing a multimo...
Enhancing patient education in breast surgery: artificial intelligence-powered guidance for mastopexy, augmentation, reduction, and reconstruction [0.03%]
乳腺手术患者教育的增强：人工智能驱动的乳房悬吊、增大、缩小和重建手术指导
Gianluca Marcaccini,Pietro Susini,Yi Xie et al.
Gianluca Marcaccini et al.
Background: Large language models (LLMs), such as ChatGPT have revolutionised patient education by offering accessible, reasonable, and empathetic guidance. This study evaluates ChatGPT's role in supporting patient inquir...